Eden Research Share Discussion Threads

[investingisatrickygame] 23/11/2023 09:42

Surely, this is just Eden using US PR as they said they would with the OTC markets.

NASDAQ not cheap for a company like Eden and no mention of spend in this way with the Placing RNS. My guess is you're barking up the wrong tree.

[supersonico] 23/11/2023 09:29

Observation;

Majority of companies that use Skyline Corporate Communications Group, LLC for investor relations are NASDAQ listed.

[kittybiscuits] 23/11/2023 08:51

Oooh, not long but thanks for enquiring.

[kittybiscuits] 21/11/2023 16:33

23 working days (ignoring the ones between Xmas and new yr. Come on regulators. Pull yer fingers out!

[alchemy] 21/11/2023 11:06

You're a rum un Neutes

[kittybiscuits] 21/11/2023 10:28

Thanks - that echoes what I am hearing.

[attyg] 21/11/2023 07:48

KittyBiscuits 15767

My understanding is Eden continue to expect Californian approval before the end of year - further they are unaware of any "dossier-type" issues which could cause any further delays. Nevertheless, regulators work at their own pace.
I also gather Eden feel there is nothing more they can do to obtain approval - their thinking being any pressure brought to bear could be counter productive.
It literally could come any day - though that has been the sense for some period of time.

That is my understanding.

[supersonico] 21/11/2023 07:32

Investing,

Considering the write up above..my guess is Syngenta related deals with Eden are highly likely inthecoming and Jealotts hill is familiar to Eden staff.. past and present.

[investingisatrickygame] 21/11/2023 07:14

Adding to Super's post above

hxxps://www.adama.com/uk/en/about-adama

[supersonico] 21/11/2023 06:10

ADAMA discussed the drivers, challenges, and trends of biologicals and launched or expanded the use of many biologicals.

The biggest hurdle we face in the development and manufacturing of biologicals is the need to develop new and innovative formulation technologies to address the unique challenges of biological products. We are also working to scale up the production of biological products to meet the growing demand and to educate farmers and growers about the benefits of biological products and how to use them effectively. To better meet the market demand, in 2022, ADAMA acquired AgriNova New Zealand Ltd. and is currently integrating its biological plant nutrition and plant growth regulators into the product portfolio.

In the past year, ADAMA has been also working on several licensing collaborations in various areas of the biological sector, and we have close about 20 such partnerships. These are with a broad range of organizations including R&D institutions, universities and commercial start-up companies.

The future development trend of biologicals is highly promising. There is a strong consumer and market need that to which we maintain our commitment and for which we continue to develop solutions.

The most important trend is the coexistence of biologicals with chemical products where appropriate, creating formulations that allow farmers to enjoy the benefits of both so that they gain effective and environmentally friendly crop protection. These combined solutions support the principle of Integrated Pest Management, and often can be a more effective pest control method than biologicals alone, while still reducing the use of chemicals.

[kittybiscuits] 20/11/2023 20:18

AttyG

The California regulators are certainly taking their sweet time approving Mevelone. Are you aware of any holdups? Sean has said it’s due before eoy, but not much of 2023 left!

[alchemy] 20/11/2023 19:10

Continue to hold . Just using Bulletin Boards as I think they should be - to tease out the truth .

[neutralpov] 20/11/2023 17:41

WARNING TO ANY POTENTIAL INVESTOR
=================================

There are only two, just perhaps three, distinct human personalities behind all these ramping posts above. One of them is a paid ramper.

This is all a charade.

Don't get fooled by this boiler room operation. Move along, plenty of 'kosher' biotechs to be found elsewhere.

[attyg] 20/11/2023 17:09

Just back from my travels to watch Scotland leak three, yes, THREE very poor goals to Noway without Haaland playing - can't remember when Scotland last leaked three goals at Hampden - if anyone knows, please do not remind me. Anyhow, we're joining England in Germany next June, so I don't care.

Alchemy wrote:

"I still ask myself - “Was the Ecovolex order a full grown-up order for delivery “? . Or orchestrated at fund raising time?"



Sean spoke in a recent video of how the size of the order was such that the Board had to consider if they could go ahead without recourse to a fund raise - and while it was concluded that it was possible, the Board nevertheless deemed the prudent course of action was to raise additional funds.
No mention was made regarding the size/value of the order - but I guess it must be significant for Eden to generate a need for further funding.

I say, if you don't trust Sean and or the Board - sell up.

It is definitely possible that Eden receives neither EA approval for Ecovelex in any country this year and possible too, that California does not grant approval for mevalone.

However, that may not equate to no sales in 2023.
Corteva may take some of the order before the year is out and I understand our Californian mevalone distributor is ready and may have placed an order for mevalone.

I sense you are impatient for the share price to travel in a northerly direction - and at some speed. While most people who have experience in Eden would retort - he doesn't have any experience of Eden time, does he - guffaw. I am inclined to point out that each approval Eden obtains for Ecovalex and Californian approval for mevalone will (I understand) generate a need for Cenkos/Cavendish to update the market and such update will require them to markedly amend the financial projections.

When sentiment changes with Eden, I expect the share price movement to meet your needs.
Of course, just sell up if you think Sean and or the Board tell porkies.

[alchemy] 20/11/2023 15:03

I'm glad there's an enemy involved ; sharpens the wits

[alchemy] 20/11/2023 14:44

Sales not invoiced or white lined by 31/12 will not count to 2023 revenue . Though steeped in potential thst means analysts won't see that if permissions don't come through to allow revenue recognition in six weeks' time.I still ask myself - "Was the Ecovolex order a full grown-up order for delivery "? . Or orchestrated at fund raising time?California go ahead would.move the dial but again one asks can it do it this year?There is an inevitability about this share coming good but when .

[supersonico] 20/11/2023 14:15

Always remember ..it's always lies, manipulation and spin.

Sabotaging EU Pesticide Reduction Law (SUR)
Pesticide industry lobby's reckless assault on biodiversity and health

[kittybiscuits] 20/11/2023 09:47

Nice write up article.

[neutralpov] 20/11/2023 09:32

supersonico 20 Nov '23 - 07:45 - 15756
> he was asked to test the headlice product.

Quite unnecessary.

We already know its a LOUSY bet!

(chuckle @ maroons)

[monet] 20/11/2023 07:59

Harvesting innovation: 5 companies cultivating a greener future with AgriTech